_id
691b08f83c536f8df2318994
Ticker
ALCJ.PA
Name
Crossject
Exchange
PA
Address
6 Rue Pauline Kergomard, Dijon, France, 21000
Country
France
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
EUR
Website
https://www.crossject.com
Description
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France.
Last Close
2.2
Volume
14286
Current Price
2.285
Change
-0.454545454545465
Last Updated
2025-12-30T12:34:43.602Z
Image
https://logo.clearbit.com/www.crossject.com
Ipo Date
-
Market Cap
114092200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
2630000
Gross Profit
-2630000
Operating Expenses
2509000
Operating Income
-5139000
Interest Expense
1143000
Pretax Income
-6424000
Net Income
-4869000
Eps
-0.09687733451196447
Dividends Per Share
-
Shares Outstanding
51860086
Income Tax Expense
-1555000
EBITDA
-2649000
Operating Margin
-
Total Other Income Expense Net
-1285000
Cash
6338000
Short Term Investments
-
Receivables
4980000
Inventories
3203000
Total Current Assets
15700000
Property Plant Equipment
5729000
Total Assets
31375000
Payables
4248000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
32491999
Equity
-2049000
Bs_currency_symbol
-
Depreciation
2630000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-56.048221908247925
ROE
237.6281112737921
ROA
-15.518725099601593
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
2630000
Quarters > 0 > income Statement > gross Profit
-2630000
Quarters > 0 > income Statement > operating Expenses
2509000
Quarters > 0 > income Statement > operating Income
-5139000
Quarters > 0 > income Statement > interest Expense
1143000
Quarters > 0 > income Statement > pretax Income
-6424000
Quarters > 0 > income Statement > net Income
-4869000
Quarters > 0 > income Statement > eps
-0.09687733451196447
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
50259434
Quarters > 0 > income Statement > income Tax Expense
-1555000
Quarters > 0 > income Statement > EBITDA
-2649000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1285000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
6338000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4980000
Quarters > 0 > balance Sheet > inventories
3203000
Quarters > 0 > balance Sheet > total Current Assets
15700000
Quarters > 0 > balance Sheet > property Plant Equipment
5729000
Quarters > 0 > balance Sheet > total Assets
31375000
Quarters > 0 > balance Sheet > payables
4248000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
32491999
Quarters > 0 > balance Sheet > equity
-2049000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
2630000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.09687733451196447
Quarters > 0 > ratios > PB
-56.048221908247925
Quarters > 0 > ratios > ROE
237.6281112737921
Quarters > 0 > ratios > ROA
-15.518725099601593
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-513000
Quarters > 1 > income Statement > cost Of Revenue
2330000
Quarters > 1 > income Statement > gross Profit
-11645000
Quarters > 1 > income Statement > operating Expenses
5392000
Quarters > 1 > income Statement > operating Income
-7736000
Quarters > 1 > income Statement > interest Expense
678000
Quarters > 1 > income Statement > pretax Income
-7578000
Quarters > 1 > income Statement > net Income
-6393000
Quarters > 1 > income Statement > eps
-0.12719999990449554
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
50259434
Quarters > 1 > income Statement > income Tax Expense
-1185000
Quarters > 1 > income Statement > EBITDA
-4741000
Quarters > 1 > income Statement > operating Margin
1507.992202729045
Quarters > 1 > income Statement > total Other Income Expense Net
158000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
7036000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4295000
Quarters > 1 > balance Sheet > inventories
3418000
Quarters > 1 > balance Sheet > total Current Assets
15880000
Quarters > 1 > balance Sheet > property Plant Equipment
5050000
Quarters > 1 > balance Sheet > total Assets
31567000
Quarters > 1 > balance Sheet > payables
4554000
Quarters > 1 > balance Sheet > short Term Debt
3199000
Quarters > 1 > balance Sheet > long Term Debt
18352000
Quarters > 1 > balance Sheet > total Liabilities
34240000
Quarters > 1 > balance Sheet > equity
-2673000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-6393000
Quarters > 1 > cash Flow > depreciation
2330000
Quarters > 1 > cash Flow > change In Working Capital
469000
Quarters > 1 > cash Flow > cash From Operations
-2439000
Quarters > 1 > cash Flow > capital Expenditures
1059000
Quarters > 1 > cash Flow > cash From Investing
-1237000
Quarters > 1 > cash Flow > cash From Financing
4762000
Quarters > 1 > cash Flow > net Change In Cash
1084000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.12719999990449554
Quarters > 1 > ratios > PB
-42.964012977927425
Quarters > 1 > ratios > ROE
239.16947250280583
Quarters > 1 > ratios > ROA
-20.252162067982386
Quarters > 1 > ratios > FCF
-3498000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
6.818713450292398
Quarters > 1 > health Score
49
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
4628000
Quarters > 2 > income Statement > cost Of Revenue
5346000
Quarters > 2 > income Statement > gross Profit
-718000
Quarters > 2 > income Statement > operating Expenses
6001000
Quarters > 2 > income Statement > operating Income
-6719000
Quarters > 2 > income Statement > interest Expense
732000
Quarters > 2 > income Statement > pretax Income
-8043000
Quarters > 2 > income Statement > net Income
-6402000
Quarters > 2 > income Statement > eps
-0.15509999904061855
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
41276596
Quarters > 2 > income Statement > income Tax Expense
-1641000
Quarters > 2 > income Statement > EBITDA
-6195000
Quarters > 2 > income Statement > operating Margin
-145.18150388936905
Quarters > 2 > income Statement > total Other Income Expense Net
-1324000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
5952000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2752000
Quarters > 2 > balance Sheet > inventories
4385000
Quarters > 2 > balance Sheet > total Current Assets
15833000
Quarters > 2 > balance Sheet > property Plant Equipment
6061000
Quarters > 2 > balance Sheet > total Assets
33128000
Quarters > 2 > balance Sheet > payables
4458000
Quarters > 2 > balance Sheet > short Term Debt
3272540
Quarters > 2 > balance Sheet > long Term Debt
20712250
Quarters > 2 > balance Sheet > total Liabilities
37242000
Quarters > 2 > balance Sheet > equity
-4114000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-6402000
Quarters > 2 > cash Flow > depreciation
2517000
Quarters > 2 > cash Flow > change In Working Capital
-1365000
Quarters > 2 > cash Flow > cash From Operations
-5518000
Quarters > 2 > cash Flow > capital Expenditures
2468000
Quarters > 2 > cash Flow > cash From Investing
-2189000
Quarters > 2 > cash Flow > cash From Financing
11368000
Quarters > 2 > cash Flow > net Change In Cash
3648000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.15509999904061855
Quarters > 2 > ratios > PB
-22.925868220709773
Quarters > 2 > ratios > ROE
155.6149732620321
Quarters > 2 > ratios > ROA
-19.325042260323595
Quarters > 2 > ratios > FCF
-7986000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.7255834053586863
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
774000
Quarters > 3 > income Statement > cost Of Revenue
4918000
Quarters > 3 > income Statement > gross Profit
-4144000
Quarters > 3 > income Statement > operating Expenses
1121000
Quarters > 3 > income Statement > operating Income
-6092000
Quarters > 3 > income Statement > interest Expense
424000
Quarters > 3 > income Statement > pretax Income
-5291000
Quarters > 3 > income Statement > net Income
-4076000
Quarters > 3 > income Statement > eps
-0.11168993558592606
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
36493888
Quarters > 3 > income Statement > income Tax Expense
-1215000
Quarters > 3 > income Statement > EBITDA
-4658500
Quarters > 3 > income Statement > operating Margin
-787.0801033591731
Quarters > 3 > income Statement > total Other Income Expense Net
801000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
2304000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4778000
Quarters > 3 > balance Sheet > inventories
3134000
Quarters > 3 > balance Sheet > total Current Assets
10675000
Quarters > 3 > balance Sheet > property Plant Equipment
5692000
Quarters > 3 > balance Sheet > total Assets
28641000
Quarters > 3 > balance Sheet > payables
4324000
Quarters > 3 > balance Sheet > short Term Debt
3465000
Quarters > 3 > balance Sheet > long Term Debt
18921000
Quarters > 3 > balance Sheet > total Liabilities
33901000
Quarters > 3 > balance Sheet > equity
-5269000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-4076000
Quarters > 3 > cash Flow > depreciation
1887000
Quarters > 3 > cash Flow > change In Working Capital
1546000
Quarters > 3 > cash Flow > cash From Operations
-1986000
Quarters > 3 > cash Flow > capital Expenditures
1924000
Quarters > 3 > cash Flow > cash From Investing
1843000
Quarters > 3 > cash Flow > cash From Financing
-2957000
Quarters > 3 > cash Flow > net Change In Cash
-3087000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.11168993558592606
Quarters > 3 > ratios > PB
-15.826254332890494
Quarters > 3 > ratios > ROE
77.35813247295502
Quarters > 3 > ratios > ROA
-14.231346670856466
Quarters > 3 > ratios > FCF
-3910000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.051679586563307
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4115000
Annuals > 0 > income Statement > cost Of Revenue
4847000
Annuals > 0 > income Statement > gross Profit
-21893000
Annuals > 0 > income Statement > operating Expenses
10345000
Annuals > 0 > income Statement > operating Income
-15238000
Annuals > 0 > income Statement > interest Expense
1429000
Annuals > 0 > income Statement > pretax Income
-15621000
Annuals > 0 > income Statement > net Income
-12795000
Annuals > 0 > income Statement > eps
-0.2827999980284674
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
45243989
Annuals > 0 > income Statement > income Tax Expense
-2826000
Annuals > 0 > income Statement > EBITDA
-9345000
Annuals > 0 > income Statement > operating Margin
-370.3037667071689
Annuals > 0 > income Statement > total Other Income Expense Net
-383000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
7036000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4295000
Annuals > 0 > balance Sheet > inventories
3418000
Annuals > 0 > balance Sheet > total Current Assets
15880000
Annuals > 0 > balance Sheet > property Plant Equipment
5050000
Annuals > 0 > balance Sheet > total Assets
31567000
Annuals > 0 > balance Sheet > payables
4554000
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
18352000
Annuals > 0 > balance Sheet > total Liabilities
34240000
Annuals > 0 > balance Sheet > equity
-2673000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-12795000
Annuals > 0 > cash Flow > depreciation
5220000
Annuals > 0 > cash Flow > change In Working Capital
-896000
Annuals > 0 > cash Flow > cash From Operations
-7957000
Annuals > 0 > cash Flow > capital Expenditures
3527000
Annuals > 0 > cash Flow > cash From Investing
-3426000
Annuals > 0 > cash Flow > cash From Financing
16130000
Annuals > 0 > cash Flow > net Change In Cash
4747000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.2827999980284674
Annuals > 0 > ratios > PB
-37.153219549195654
Annuals > 0 > ratios > ROE
478.675645342312
Annuals > 0 > ratios > ROA
-40.532834922545696
Annuals > 0 > ratios > FCF
-11484000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.7907654921020657
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
145000
Annuals > 1 > income Statement > cost Of Revenue
18498000
Annuals > 1 > income Statement > gross Profit
-6135000
Annuals > 1 > income Statement > operating Expenses
-3947000
Annuals > 1 > income Statement > operating Income
-11800000
Annuals > 1 > income Statement > interest Expense
497000
Annuals > 1 > income Statement > pretax Income
-11505000
Annuals > 1 > income Statement > net Income
-8638000
Annuals > 1 > income Statement > eps
-0.22636309867444726
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
38159930
Annuals > 1 > income Statement > income Tax Expense
-2867000
Annuals > 1 > income Statement > EBITDA
-7297000
Annuals > 1 > income Statement > operating Margin
-8137.931034482759
Annuals > 1 > income Statement > total Other Income Expense Net
293000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2304000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4778000
Annuals > 1 > balance Sheet > inventories
3134000
Annuals > 1 > balance Sheet > total Current Assets
10675000
Annuals > 1 > balance Sheet > property Plant Equipment
5692000
Annuals > 1 > balance Sheet > total Assets
28641000
Annuals > 1 > balance Sheet > payables
4324000
Annuals > 1 > balance Sheet > short Term Debt
3599000
Annuals > 1 > balance Sheet > long Term Debt
18921000
Annuals > 1 > balance Sheet > total Liabilities
33910000
Annuals > 1 > balance Sheet > equity
-5269000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-8638000
Annuals > 1 > cash Flow > depreciation
4504000
Annuals > 1 > cash Flow > change In Working Capital
-679000
Annuals > 1 > cash Flow > cash From Operations
-6201000
Annuals > 1 > cash Flow > capital Expenditures
6403000
Annuals > 1 > cash Flow > cash From Investing
-2636000
Annuals > 1 > cash Flow > cash From Financing
3358000
Annuals > 1 > cash Flow > net Change In Cash
-5479000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.22636309867444726
Annuals > 1 > ratios > PB
-15.89695318846081
Annuals > 1 > ratios > ROE
163.94002657050675
Annuals > 1 > ratios > ROA
-30.159561467825846
Annuals > 1 > ratios > FCF
-12604000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-86.92413793103448
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
954000
Annuals > 2 > income Statement > cost Of Revenue
14848000
Annuals > 2 > income Statement > gross Profit
-13894000
Annuals > 2 > income Statement > operating Expenses
12082000
Annuals > 2 > income Statement > operating Income
-13228000
Annuals > 2 > income Statement > interest Expense
277000
Annuals > 2 > income Statement > pretax Income
-13379000
Annuals > 2 > income Statement > net Income
-11157000
Annuals > 2 > income Statement > eps
-0.3068507841045518
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
36359692
Annuals > 2 > income Statement > income Tax Expense
-2222000
Annuals > 2 > income Statement > EBITDA
-8025000
Annuals > 2 > income Statement > operating Margin
-1386.5828092243187
Annuals > 2 > income Statement > total Other Income Expense Net
-91000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
7770000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3519000
Annuals > 2 > balance Sheet > inventories
2004000
Annuals > 2 > balance Sheet > total Current Assets
13830000
Annuals > 2 > balance Sheet > property Plant Equipment
7669000
Annuals > 2 > balance Sheet > total Assets
32860000
Annuals > 2 > balance Sheet > payables
3521000
Annuals > 2 > balance Sheet > short Term Debt
2642920
Annuals > 2 > balance Sheet > long Term Debt
14126000
Annuals > 2 > balance Sheet > total Liabilities
30174000
Annuals > 2 > balance Sheet > equity
2021000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-11157000
Annuals > 2 > cash Flow > depreciation
5263000
Annuals > 2 > cash Flow > change In Working Capital
400000
Annuals > 2 > cash Flow > cash From Operations
-5080000
Annuals > 2 > cash Flow > capital Expenditures
6778000
Annuals > 2 > cash Flow > cash From Investing
-6778000
Annuals > 2 > cash Flow > cash From Financing
9639000
Annuals > 2 > cash Flow > net Change In Cash
-2059000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.3068507841045518
Annuals > 2 > ratios > PB
39.49011575457694
Annuals > 2 > ratios > ROE
-552.0534388916378
Annuals > 2 > ratios > ROA
-33.9531345100426
Annuals > 2 > ratios > FCF
-11858000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-12.429769392033544
Annuals > 2 > health Score
9
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
912000
Annuals > 3 > income Statement > cost Of Revenue
11975000
Annuals > 3 > income Statement > gross Profit
-11063000
Annuals > 3 > income Statement > operating Expenses
975000
Annuals > 3 > income Statement > operating Income
-11823000
Annuals > 3 > income Statement > interest Expense
845000
Annuals > 3 > income Statement > pretax Income
-12624000
Annuals > 3 > income Statement > net Income
-10806000
Annuals > 3 > income Statement > eps
-0.41551717872833516
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
26006145
Annuals > 3 > income Statement > income Tax Expense
-1818000
Annuals > 3 > income Statement > EBITDA
-7333000
Annuals > 3 > income Statement > operating Margin
-1296.3815789473686
Annuals > 3 > income Statement > total Other Income Expense Net
-801000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
9829000
Annuals > 3 > balance Sheet > short Term Investments
154000
Annuals > 3 > balance Sheet > receivables
1666000
Annuals > 3 > balance Sheet > inventories
1661000
Annuals > 3 > balance Sheet > total Current Assets
13490000
Annuals > 3 > balance Sheet > property Plant Equipment
7146000
Annuals > 3 > balance Sheet > total Assets
31525000
Annuals > 3 > balance Sheet > payables
1961000
Annuals > 3 > balance Sheet > short Term Debt
1018999
Annuals > 3 > balance Sheet > long Term Debt
23327000
Annuals > 3 > balance Sheet > total Liabilities
37006000
Annuals > 3 > balance Sheet > equity
-6146000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-10806000
Annuals > 3 > cash Flow > depreciation
4490000
Annuals > 3 > cash Flow > change In Working Capital
-327320
Annuals > 3 > cash Flow > cash From Operations
-6083710
Annuals > 3 > cash Flow > capital Expenditures
6732620
Annuals > 3 > cash Flow > cash From Investing
-6732620
Annuals > 3 > cash Flow > cash From Financing
14522300
Annuals > 3 > cash Flow > net Change In Cash
1706000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.41551717872833516
Annuals > 3 > ratios > PB
-9.287908928571428
Annuals > 3 > ratios > ROE
175.82167263260658
Annuals > 3 > ratios > ROA
-34.27755749405234
Annuals > 3 > ratios > FCF
-12816330
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-14.052993421052632
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.09687733451196447
Valuation > metrics > PB
-56.048221908247925
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
237.6281112737921
Profitability > metrics > ROA
-31.012738853503187
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.496062992125984
Risk > final Score
12
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.6958568738229753
Liquidity > metrics > Quick Ratio
2.941854990583804
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
70
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-16
Prev Risks > 1
-7
Prev Risks > 2
-27
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
83
Updated At
2026-01-20T23:08:34.012Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-24
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-29
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-20
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.14
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-16
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.17
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-24
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.19
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.19
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-22
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.23
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.23
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-29
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.17
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.17
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-18
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.26
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.26
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-26
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.25
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.25
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-09
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.27
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.27
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-13
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.38
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.38
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-26
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.51
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.51
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-05-18
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.47
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.47
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-11-27
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.38
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.38
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-03-31
Earnings History > 15 > report Date
2017-05-05
Earnings History > 15 > date
2017-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.49
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.49
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-20
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.41
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.41
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-03-31
Earnings History > 17 > report Date
2016-04-29
Earnings History > 17 > date
2016-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.32
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.32
Earnings History > 17 > surprise Percent
-
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AALCJ.PA rises 10.96% intraday on 06 Jan 2026: watch EUR 2.40 high for momentum Meyka
Read more →Crossject Société Anonyme (EPA:ALCJ) Is About To Turn The Corner simplywall.st
Read more →Showing 2 of 3
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Crossject
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.